CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Huadong Medicine Company Limited Company Snapshot
Huadong Medicine Company Limited operates in the Drugs, proprietaries, and sundries sector. In addition to historical fundamental analyses, the complete report available to purchase compares Huadong Medicine Company Limited with three other companies in this sector in China: Zhejiang International Group Company Limited (2016 sales of 17.26 billion Chinese Renmimbi [US$2.55 billion] of which 100% was Medicine Retailing), Yunnan Baiyao Group Co., Ltd. (22.41 billion Chinese Renmimbi [US$3.31 billion] of which 59% was Comodities Trading), and China Medicine Health Industry Co Ltd (25.74 billion Chinese Renmimbi [US$3.80 billion] of which 67% was Pharmaceutical Business).

Sales Analysis. Huadong Medicine Company Limited reported sales of 25.38 billion Chinese Renmimbi (US$3.75 billion) for the year ending December of 2016. This represents an increase of 16.8% versus 2015, when the company's sales were 21.73 billion Chinese Renmimbi. Sales at Huadong Medicine Company Limited have increased during each of the previous five years (and since 2011, sales have increased a total of 128%). Sales of Manufacturing saw an increase of 17.8% in 2016, from 4.97 billion Chinese Renmimbi to 5.85 billion Chinese Renmimbi. Not all segments of Huadong Medicine Company Limited experienced an increase in sales in 2016: sales of Other Operating fell 10.1% to 33.80 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Huadong Medicine Company Limited
  Stock Performance Chart for Huadong Medicine Company Limited
 
  Stock Data: Recent Stock Performance:
  Current Price (7/21/2017): 46.77
(Figures in Chinese Renmimbi)
1 Week -2.9%   13 Weeks -6.8%  
4 Weeks 1.8%   52 Weeks 36.9%  
 
Huadong Medicine Company Limited Key Data:
  Ticker: 000963 Country: China
  Exchanges: SZN Major Industry: Health Care Equipment & Services
    Sub Industry: Drugs, Proprietaries, & Sundries
  2016 Sales 25,379,337,230
(Year Ending Jan 2017).
Employees: 7,001
  Currency: Chinese Renmimbi Market Cap: 45,465,884,776
  Fiscal Yr Ends: December Shares Outstanding: 972,116,416
  Share Type: A Gu Closely Held Shares: 588,644,178
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.